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Case
A young girl (4 years 11 months of age) was
referred to the Pediatric Environmental
Health Subspecialty Unit at Boston’s
Children’s Hospital (PEHSU) for evaluation.
She had been previously diagnosed by her
pediatrician as having allergies, frequent otitis
media, congestion, sinusitis, and reactive air-
way disease, with cough-equivalent bron-
chospasm especially prominent during upper
respiratory infections and exercise. During
infancy the patient had been diagnosed with
poor weight gain due to a milk allergy and
treated with an elemental milk and then soy
formula. There was a family history of atopy;
the father and secondary relatives had child-
hood asthma and hay fever. Previous allergy
testing was positive only for cat dander; ther-
apy included inhaled bronchodilators,
steroids, antihistamines, and cromolyn. 
At home, the family allowed no tobacco
smoking and had reordered the house to
make it more habitable for the patient. They
had removed all carpeting and covered the
mattress on the child’s bed. The house was
frequently dusted and the gas-ﬁred furnace
and ductwork were regularly cleaned.
The patient’s mother was concerned that
her daughter’s symptoms were becoming
worse with a variety of environmental triggers
and an expanding list of symptoms. Volatile
organic chemicals, cleaning compounds,
detergents, perfumes, cigarette smoke, dust,
and paints caused new symptoms of pruritis,
headache, fatigue, nausea, difﬁculty breathing,
and malaise. The patient was on a restricted
and rotating diet, which included goat cheese
and duck eggs, because of her food allergies to
citrus, seafood, foods containing preservatives,
and meats. The parents had purchased only
all-cotton clothing for the patient because
polyesters and other artiﬁcial ﬁbers made her
itch and reportedly caused rashes. The parents
had also sought help from a naturopath, who
had found multiple allergies. The patient was
regularly given certain herbal preparations,
including echinacea, astralagus, pulsatilla, bry-
onia, forscolin, and quercidin, with some
relief of symptoms, according to the parents.
The child frequently had olfactory warn-
ing when chemicals in the environment were
going to exacerbate her symptoms; whenever
she voiced her anxieties, the family then
quickly left the environment. Thus the
patient had begun to severely limit her activi-
ties because of her multiple chemical sensitiv-
ities (MCS). For example, the mother no
longer took her daughter into public
restrooms or grocery stores because the disin-
fectants caused dizziness, fatigue, headache,
chest tightness, and nausea. After the patient
visited the PEHSU, her mother complained
that some areas of the hospital had been
freshly painted and that the patient had later
become symptomatic with an asthma attack.
She feared that the patient’s imminent transi-
tion into public school kindergarten would
likely be sabotaged by the school’s routine
use of pesticides and cleaning products. The
school had supplied her in advance with
material safety data sheets covering 15 com-
mercial products, which contained more than
35 chemicals applied indoors during the rou-
tine maintenance at the school. School ofﬁ-
cials denied that any renovations were
planned, but they promised to work with the
parents to limit the patient’s contact with
chemical exposures.
A physical examination revealed a frail-
appearing child with no evidence of rashes or
eczema. The eye, nose, and throat exam
showed mild nasal turbinate swelling and
redness, but no involvement of the conjunc-
tiva or throat. The patient’s lungs were clear,
and the heart and abdomen, as well as the
rest of the exam, were within normal limits.
Previous blood work, including peripheral
eosinophil count and serum IgE level, was
negative or normal.
The family was counseled about keeping
a home symptom diary. Pulmonary function
testing was recommended when the patient
becomes old enough to cooperate. Coping
measures and feedback to empower the
patient were discussed. Anticipatory guidance
was given on working with school ofﬁcials to
limit the environmental impact on the
patient’s school attendance. Follow-up 9
months later revealed continued respiratory
and other symptoms with limited effective-
ness of avoidance strategies, environmental
controls, herbs, and medications. The patient
had missed 15 days of her half-day kinder-
garten due to her symptoms, which seemed
to be worsened by the school’s use of a new
carpet-cleaning solution.
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Multiple chemical sensitivities (MCS) syndrome, also known as idiopathic environmental intoler-
ance, is a controversial diagnosis that encompasses a wide range of waxing and waning, subjective
symptoms referable to more than one body system and provoked by exposure to low levels of
chemicals, foods, or other agents in the environment. Although MCS has been studied extensive-
ly, a unifying mechanism explaining the illness remains obscure, and clinicians are divided as to
whether such a medical entity exists separately from psychosomatic syndromes. MCS is an adult
diagnosis; there is little reference to pediatric cases in the scientiﬁc literature. In this case from the
Pediatric Environmental Health Subspecialty Unit at Boston’s Children’s Hospital, I present the
case of a preschool child who had suffered from milk allergy and poor weight gain as an infant,
and then later developed asthma, allergic symptoms, sinusitis, headaches, fatigue, and rashes pre-
cipitated by an expanding variety of chemicals, foods, and allergens. I review deﬁnitions, mecha-
nisms, diagnostic strategies, and management, and discuss some uniquely pediatric features of
MCS as illustrated by this case. Key words: idiopathic environmental intolerance, multiple chemi-
cal sensitivities. Environ Health Perspect 108:1219–1223 (2000). [Online 20 November 2000]
http://ehpnet1.niehs.nih.gov/docs/2000/108p1219-1223woolf/abstract.html
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HARVARD MEDICAL SCHOOLA controversial syndrome in adults
known as MCS is characterized by a range of
disparate symptoms involving the skin, vas-
cular, genitourinary, musculoskeletal, gas-
trointestinal, pulmonary, and central nervous
systems, which are “triggered” by low-dose
exposures to chemicals, foods, biologicals, or
other toxic agents in the environment. Often
adult MCS syndrome is initially precipitated
by an exposure to a chemical in the work-
place; subsequently the patient develops
more and more intolerance to an array of
foods, chemicals, and other “incitants” until
he or she is functionally disabled. However,
many clinicians question the validity of MCS
as a medical entity and include it among
“fashionable diagnoses” such as chronic
fatigue syndrome or ﬁbromyalgia, represent-
ing somatization of essentially psychologic
complaints (1). Clinicians, researchers, and
health policy makers cannot even agree on
the name of this entity. MCS is also known
as idiopathic environmental intolerance,
environmental illness, environmental hyper-
sensitivity, and universal reactors. MCS as a
construct is felt by some to overlap with sick
building syndrome (2,3) or the Gulf War
syndrome (4,5). 
MCS was recently reviewed by Kipen
and Fiedler (6). Yet children, such as the
case presented here, whose illnesses resemble
the adult syndrome of MCS have been
referred to our PEHSU. The American
Academy of Pediatrics includes MCS in its
recently published Handbook of Pediatric
Environmental Health, but offers no diagnos-
tic criteria (7). Indeed it suggests that such
diverse childhood maladies as attention
deﬁcits, learning disorders, sick building syn-
drome, and hyperactivity syndromes can
share elements with and overlap MCS. 
Pediatric case definition. The case
described in this paper meets certain deﬁni-
tional characterstics of MCS, such as a)
effects on more than one body system; b) the
occurrence of a variety of chemical, food,
and biologic agent triggers at low-level con-
centrations; c) spreading of the incitant
agents responsible for symptoms; d) progres-
sive involvement of body systems;  and e) the
lack of a diagnostic or an abnormal labora-
tory assay. Although this child had been
previously diagnosed with milk intolerance,
asthma, and sinusitis, no one unifying set of
diagnoses or explanations seemed to satisfy
her range of symptoms or the progressive
nature of her sensitivities. As the case with
this child, many adults with MCS report the
spreading nature of their intolerance to low-
level environmental toxic agents—more and
more toxicants must be avoided as time goes
on. Diverse precipitants of symptoms have
been postulated: biological agents, electro-
magnetic radiation, off-gassing construction
materials and home decorations, foods, pes-
ticides, synthetics, perfumes, other toiletries,
and the like are cited as common offenders.
The diagnosis of MCS in children differs
from that in adults in some signiﬁcant ways.
For example, many adults with MCS cite a
workplace chemical exposure as the precipi-
tant of the disease, and the illness has been
addressed as an occupational health issue
(8–12). For children, the incitant is more
likely to be found in the home or school.
Many symptoms in adults are subjective and
often include fatigue, malaise, headache,
dizziness, burning sensations, breathlessness,
a “mental fog” of impaired cognition, and
paresthesias; no objective laboratory abnor-
malities characterize the disorder. In the case
presented here, the parents largely provided
the history (and the interpretation) of the
child’s symptoms, complaints, and reactions.
Young children are often not able to pin-
point or articulate their own symptoms well.
They cannot recall the time course of their
own symptoms or associated findings, and
clinicians must rely on parents to recount
their observations of their child’s health.
Because there is no single objective test ﬁnd-
ing to confirm the diagnosis of MCS, its
diagnosis in children will often rest largely
on historical information obtained from the
parents.
MCS deﬁnitional criteria have been pre-
viously devised for adults (13); these are
summarized in Table 1, but modiﬁed to be
more applicable to pediatric cases. The 
progressive nature of symptoms titered to
smaller and smaller doses of precipitants
(triggers, allergens, incitants), the olfactory
warning of offending odors, and the progres-
sive restrictions upon the patient’s activities
and habitable environments all characterize
the unfortunate victims of this condition,
although there is no unifying theme that
covers the spectrum of MCS syndrome. 
Etiologic theories. The etiology of MCS
syndrome remains a mystery. Mechanisms
postulated to explain MCS have been
reviewed in detail elsewhere (6,14,15).
Although immune disorders have been
invoked, there are no convincing scientific
studies that document any speciﬁc immune
abnormalities in patients with MCS (16,17).
Olfactory warning of noxious odors seems to
be a hallmark of MCS; a mechanism of neu-
rotoxicity from chemical toxicants carried to
the central nervous system (hypothalamus,
amygdala, and limbic system) by way of the
olfactory bulb has been offered as one mecha-
nism of causation (18–20). Similar sensitiza-
tion of the nervous system via the respiratory
tract (instead of the olfactory bulb) by the
inhalation of low-dose toxicants has been pos-
tulated (21), but in an attempt to measure
pulmonary function changes during provoca-
tive challenges to 15 patients with MCS,
Leznoff (22) could not document any abnor-
malities. Learned behaviors conditioned by
olfactory sensitization or “limbic kindling” as
a phobic response to chemical “triggers” have
been discounted by Staudenmayer (23) as
unproven, without any physiologic basis, and
no different from simple panic attacks. None
of these theories has been validated by scien-
tific, methodologically sound research and
none has been investigated in pediatric
patients. 
Pediatric diagnosis. The diagnostic crite-
ria outlined in Table 1 seem generalizable to
children, and could tentatively be used as a
guide for clinicians evaluating pediatric cases,
although such definitional issues have not
been scientiﬁcally explored in children. The
diagnosis of MCS in children involves a care-
ful medical and environmental history and a
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Table 1. Clinical diagnostic criteria of MCS syndrome in children.
Nature of incitants provoking a response
Responses to offending environmental toxicants occur at levels of exposure below the 2.5 percentile for response 
in the general population
Child responds to multiple substances that are unrelated chemically (i.e., causes lack speciﬁcity). The symptoms are
not conﬁned to one or several environments (e.g., only sick buildings)
Biologic plausibility, identiﬁable exposure
Symptoms are reproducible with exposure with reasonable consistency
Symptoms resolve after removal of incitant exposures
An identiﬁable exposure preceded the onset of the problem
Topology of responses
Adverse responses affect more than one bodily system
Primary complaints include neuro-psychologic symptoms
The child exhibits altered sensitivity to odor
Persisting nature of perceived changes
The disorder is chronic
Differential diagnosis
No single, accepted test of physiologic function correlates with the symptoms
Subjective responses and ameliorative actions of affected children
The caretakers and/or child perceive the child’s response as unpleasant or disturbing
The family has sought professional advice
The individual’s caretakers believe he or she has a disorder
The family takes action to avoid exposures to symptom-inducing chemicals
Modiﬁed from Nethercott et al. (13 ).detailed physical examination. Testing of
hair, blood, urine, or other tissues as a screen-
ing measure for excessive environmental 
toxins is generally not helpful. The assess-
ment should be directed toward the exclusion
of other diagnoses, such as asthma, simple
migraine, allergies, or an immune disorder.
Radioallergosorbent tests, serum IgE concen-
trations, and skin testing for common aller-
gens may be helpful diagnostic procedures in
some children to conﬁrm a diagnosis of atopy
or allergies. Pulmonary function testing may
reveal airway obstruction in cases of child-
hood asthma. 
Alternative practitioners who call them-
selves “environmental practitioners” or
“clinical ecologists” claim that provoca-
tion–neutralization challenges by sublingual
or dermal application or parenteral injection
of the identified toxicants can diagnose
adults with MCS. However, the American
College of Physicians reviewed 15 studies of
provocation–neutralization testing per-
formed by clinical ecologists and criticized
the introduction of bias, lack of controls,
and their uniformly poor methodologic
designs (24). There is little information
about whether such diagnostic tests have
been applied to children or have any use in
the diagnosis of childhood MCS.
Psychiatric conditions. Previous studies
in adults have suggested a strong psychologic
component to MCS. Some victims of MCS
were found to have attention-seeking, bor-
derline personalities, panic attacks, other
anxiety or affective disorders, or other
somatoform syndromes (23,25–28). Such
findings suggest that children presenting
with symptoms resembling MCS should be
assessed for psychiatric complaints, although
there are no pediatric studies of psychologic
comorbidities in MCS. 
Family dynamics and MCS. The evalua-
tion of MCS in children should include a
careful family history of psychiatric and
medical conditions. A positive family history
for psychiatric diagnoses and treatment may
be common in victims of MCS (29).
Comorbidities such as posttraumatic stress
syndrome or childhood physical or sexual
abuse may also have roles as underlying
determinants of vulnerability to the later
development of MCS in adulthood (23).
There are no pediatric reports in which
MCS was found to be the presenting mani-
festation of underlying child physical or
sexual abuse; however, the parent–child rela-
tionship must be examined. A careful assess-
ment of the parents’ level of anxiety, their
interpretations of home or school-related
events, and their reactions to the clinician’s
proffered advice is important in the evalua-
tion of the child. If a form of abuse is sus-
pected, consultation with social services
and/or a trial of separation of the child from
the parent may be warranted.
Parental preconceptions and expectations
can shape their interactions with and beliefs
about their children’s health, reinforcing or
extinguishing a child’s behaviors or erro-
neously attributing their symptoms to envi-
ronmental precipitants. For many (but not
all) such families, MCS may serve as a coping
strategy or a more socially acceptable medical
condition within which to express depressive
symptomatology. Children may be attracted
to the attention they gain when they are in
the dependency role of patient. Sometimes
such belief systems may become ﬁxed because
of a high level of parental anxiety about the
child’s health and their perception of the
child’s vulnerability to harmful toxins. In cer-
tain circumstances, diagnoses such as school
phobia, psychiatric disorders of the parents
and/or children, or other dysfunctional family
dynamics must be considered with the differ-
ential diagnosis in the evaluation of children
presenting ostensibly with MCS syndrome. 
Factitious histories may complicate the
diagnosis of MCS. Munchausen by proxy
syndrome (MbPS) has been deﬁned as fabri-
cated history (30,31) in which a) a child’s
medical problems do not respond to treat-
ment or they follow an unusual course; b)
physical and laboratory findings made in
relation to the illness cannot be explained,
are very unusual, or are considered implausi-
ble; c) the signs and symptoms of a child’s
illness fail to occur in the parent’s absence;
d) the family history discloses numerous
medical problems that are difficult to sub-
stantiate, and their veracity is doubtful; and
e) the family history discloses similar unex-
plained illness in other children.
Meadow (32) warned clinicians not to
confuse MbPS with such problems as unrec-
ognized physical abuse, failure to thrive,
overanxious parents, parents with a delusion-
al disorder, school phobia, “hysteria by
proxy,” or simple “doctor shopping.” These
alternative diagnoses should be considered in
childhood cases of MCS syndrome as well.
Some cases of childhood MCS may overlap
with MbPS, based on the above deﬁnition.
In a case series of men as perpetrators of
MbPS, Meadow (33) described one father
who was treating his 4-year-old son for
alleged bowel disorders, allergy, and anemia
with bizarre diets and enemas. Another
father claimed that there were dangerous gas
and water supplies causing the illness, lead-
ing to formal complaints and litigation
against the public utilities (33).
Likewise, practitioners may buy into the
parent’s view of the illness because “medical-
ization” of the condition allows for easier
diagnostic and treatment options than does
the investigation and management of the
complaints within the context of a psychoso-
matic syndrome. 
Diagnostic and psychosocial issues of chil-
dren suffering from an MCS-like syndrome
are outlined in Table 2. 
Use of health care. The demands of adult
patients with MCS on health care profession-
als, their high use of health care resources,
and their dissatisfaction with proffered
advice, especially if that advice suggests psy-
chologic counseling as a management option,
are frustrating for both parties. Adult MCS
patients are high-frequency users of medical
facilities and suffer a considerable amount of
functional disability because of their com-
plaints and the strategies they must employ
to get through the day (35). Parental over-use
of services can be frustrating to pediatric
health care providers, who must nevertheless
continue to offer both their availability and
support in the best interests of the child.
Environmental restrictions. Many
patients restrict their activities and recon-
struct their habitats so that they can avoid the
environmental agents that cause symptoms,
essentially living in a relatively chemical-free
environment. Some adults use barrier cloth-
ing such as special masks, gloves, coveralls,
and even self-contained breathing apparatus
in the attempt to avoid chemical triggers.
The disability in an adult is that he or she is
isolated from others socially and cannot hold
a job (35). Children who cannot attend
school or develop normal peer relationships
because of MCS syndrome would be similar-
ly disabled (36,37). As illustrated by the case
of this 4-year-old girl, caretakers may some-
times require that schools provide prior noti-
ﬁcation of their intended use of pesticides or
other chemicals on school grounds so that
children can be kept at home on those days.
There are pressures on legislators to mandate
that public places be chemical-free so that
symptoms are not provoked in sensitive indi-
viduals (38), as mentioned in the “Public
health and psychosocial issues” in Table 2.
Dietary modifications and other reme-
dies. Therapies for MCS syndrome have
included restricted diets and avoidance of
environmental triggers. Patients with MCS
syndrome seek out a variety of treatments
not only from physicians but also clinical
ecologists, naturopaths, and other practition-
ers. Clinical ecologists use a number of
unproven therapies, such as rotating diversi-
fied diets or desensitization routines that
include frequent injections or sublingual or
dermal application of incitants. 
Clinical ecologists and other alternative
practitioners may recommend herbs and
minerals to treat their patients by improving
their tolerance of the environment (39).
Some clinical ecologists postulate that MCS
sufferers have deﬁcits of essential cofactors or
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tion; they prescribe dietary supplements,
oxygen, antioxidants, or vitamins to repair
such unproven deﬁciencies. Clearly allergic
symptoms may respond to desensitization,
bronchodilators, and other allergy medica-
tions; however, medications are rarely used
as treatments by alternative practitioners. 
As outlined in Table 2, some therapies
used to treat MCS hold special risks for chil-
dren, and their use should be discouraged.
Herbal products used to treat children can
be harmful as well as beneﬁcial (40). Parents
should be warned against using potentially
harmful and expensive remedies, such as
repeated catharsis, gamma globulin injec-
tions, chelation, or “sweat therapies,” advo-
cated by some practitioners when there is no
scientific evidence that these are effective
strategies for the treatment of MCS. Infants
and young children are generally more sus-
ceptible than adults to cathartics (41) and to
dehydration and electrolyte abnormalities by
virtue of their small size, restricted access to
replacement ﬂuids, and immature renal con-
centrating system (42).
Psychologic approaches and coping strate-
gies. Newer biopsychologic modalities of
management, including biofeedback, electro-
physiologic monitoring, coping strategies,
family-centered therapy, and behavioral
modification (psychologic desensitization)
techniques, are worth investigating in chil-
dren (43). Breaking through the mistrust of
families and their hostility to allopathic med-
icine is important; MCS-affected children
and their parents must be accorded the same
compassion and respect given to all other
groups of patients (7). School systems, social
services, and other community-based agen-
cies should offer to work with families in
helping to cope with the illness. 
Future studies. The Council on Scientiﬁc
Affairs of the American Medical Association,
the American College of Physicians, the
American College of Occupational and
Environmental Medicine, and other profes-
sional groups have all issued position papers
that are openly skeptical of MCS as a distinct
medical entity (15,24,44). They call for more
scientiﬁc research into the tenets of clinical
ecology and MCS in order to subject the
numerous theories concerning these disorders
to the peer review of evidence-based, con-
trolled investigation. Research is made more
difﬁcult because of the lack of objective ﬁnd-
ings; some patients claim that their chemical
sensitivities may shift from one chemical
agent to another without warning. The olfac-
tory warning invoked by MCS sufferers
makes the design of double-blinded studies
problematic. Whatever the difﬁculties, such
scientific investigations should also be
extended to children whose complaints
resemble those of adults suffering from MCS
syndrome so that better solutions can be
offered to those children and their families
disabled by this disorder. 
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Table 2. Pediatric considerations in multiple chemical sensitivities.
Diagnosis There is no agreed upon case deﬁnition of MCS in adults and little that is evidence-based in the diagnosis or treatment of adults. 
There is even less known about children so diagnosed.
It has been proposed that children’s learning disorders or attentional deﬁcit hyperactivity disorder (ADHD) might be explained by 
MCS, but without any convincing scientiﬁc evidence.
Adults with MCS have often been diagnosed with psychiatric conditions such as anxiety neurosis, somatoform syndromes, or depression. 
It is unknown whether affected children or their parents or caretakers have speciﬁc psychiatric diagnoses. However, it seems 
evident that they are living with considerable psychosocial stress and pain.
Management Parents will frequently shop for a doctor and seek alternative practitioners because of their frustrations and dissatisfaction with the 
response of physicians to their child’s MCS. 
It may be difﬁcult for health care providers to communicate with parents who hold such a system of ﬁxed beliefs about their child’s ill 
health and perceived environmental toxins.
Therapies recommended by clinical ecologists may engender additional risks if used for children. For example, severely restricted diets 
can interfere with the basic nutritional requirements needed for normal growth and development.
Other therapies recommended, such as desensitization, herbs, or vitamins, may be especially harmful to children, whose developing 
body systems (e.g. central nervous and immune systems) are particularly vulnerable to injury. 
Young children may have a limited capacity to detoxify certain herbs, hormones, and remedies through the liver and kidneys, with a 
consequent higher risk of toxic reactions. 
Infants and young children are particularly vulnerable to ﬂuid and electrolyte imbalances provoked by laxatives or purging; they may not 
have the capacity to detoxify and eliminate herbs, minerals, and dietary supplements used by clinical ecologists and other practitioners 
as remedies in adults. 
Public health and psychosocial issues Many adult MCS patients implicate an incident in the workplace that involved a chemical exposure as the inciting agent. For 
children, school or home would logically be the commonly implicated site of the triggering exposure to a food, drug, or chemical.
The social isolation that accompanies chemical avoidance strategies is particularly disabling for children. Such isolation impairs a 
child’s ability to make friends and otherwise interferes with normal psychosocial development. Avoidance of school may impair their 
intellectual development.
Children as well as adults are entitled to the same protections afforded by federal laws under the Americans with Disabilities Act 
(34). This federal law has been applied to include patients with MCS. For children, the law could be interpreted to include 
prior notiﬁcation of parents if pesticide spraying or other chemical applications were planned at a school or day care center. The law 
might mandate other accommodation of the special needs of a child with MCS.
Children depend on adults to make responsible choices concerning their health that are in their best interests. The diagnosis of MCS 
can lead to lifestyle choices that may add stress to family relationships, especially if parents disagree between themselves or with 
health care professionals on the diagnosis and management options open to them. Grand Rounds in Environmental Medicine • Multiple chemical sensitivities in a 4-year-old girl
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Check us out!
The Environmental Health Information Service (EHIS) offers online, searchable access to:
• • Environmental Health Perspectives
• • Environmental Health Perspectives Supplements
• • National Toxicology Program Technical and Toxicity Reports
• • Report on Carcinogens
• • Chemical Health and Safety Database
• • Rodent Historical Control Database
For more information on ordering see http://ehis.niehs.nih.gov/ or call 1-800-315-3010.
http://ehis.niehs.nih.gov/